• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CXSL2500402 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-05-21 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500400 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-05-21 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500335 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-04-28 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500257 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-04-01 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500231 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-03-18 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500157 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-02-18 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500109 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-02-08 Shanghai Shengdi Pharmaceutical Co Ltd view
CYSB2500036 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) Supplementary Application 2025-02-07 Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd view
CXSL2500093 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-01-27 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500081 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-01-25 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2500041 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2025-01-14 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400913 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-12-27 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400872 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-12-17 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400867 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-12-14 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400822 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-12-05 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400651 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-09-26 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400640 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-09-25 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400577 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-08-29 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSL2400538 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(2.2) New Drug Application 2024-08-13 Shanghai Shengdi Pharmaceutical Co Ltd view
CXSB2400080 阿得贝利单抗注射液 Adebrelimab Injection Biological Products(1) Supplementary Application 2024-07-30 Shanghai Shengdi Pharmaceutical Co Ltd;Suzhou Suncadia Biopharmaceuticals Co Ltd view